Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087150 · ClinicalTrials.gov registry record · NA
Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 323
- Enrollment target
NCT02087150 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 323 participants.
The verdict
NCT02087150, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 323 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether Eustachian tube dilation in conjunction with medical management or medical management alone is effective for treating Eustachian tube dysfunction.
Interventions
- DEVICE Acclarent Eustachian Tube Balloon Catheter (ETBC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2014-02-01 |
| Est. Completion | 2017-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02087150
The ClinicalTrials.gov registry entry for NCT02087150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acclarent Eustachian Tube Balloon Catheter (ETBC) is the first listed.
NCT02087150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02087150 about?
NCT02087150 is a clinical study titled "Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter". The objective of this study is to determine whether Eustachian tube dilation in conjunction with medical management or medical management alone is effective for treating Eustachian tube dysfunction.
What is the current status of trial NCT02087150?
This trial is currently completed. It is a NA study. The enrollment target is 323 participants. The study started on 2014-02-01. Estimated completion is 2017-01-12.
What interventions are being tested in trial NCT02087150?
The interventions under investigation include: Acclarent Eustachian Tube Balloon Catheter (ETBC) (DEVICE).
Who is sponsoring clinical trial NCT02087150?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.